Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pertuzumab”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03414658
What this trial is testing

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

Who this might be right for
Breast Cancer
Adrienne G. Waks 100
Not applicableEnded earlyNCT01996410
What this trial is testing

The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients

Who this might be right for
Breast Cancer Stages I Through III
OhioHealth 10
Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Study completedNCT01669239
What this trial is testing

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 83
Testing effectiveness (Phase 2)Study completedNCT03272477
What this trial is testing

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Palleos Healthcare GmbH 257
Post-approval studies (Phase 4)UnknownNCT05036005
What this trial is testing

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

Who this might be right for
Breast CancerBreast NeoplasmsBreast Cancer Female+1 more
Institut fuer Frauengesundheit 108
Post-approval studies (Phase 4)Study completedNCT02445586
What this trial is testing

Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT01461057
What this trial is testing

Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06973525
What this trial is testing

This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 30
Not applicableLooking for participantsNCT06197581
What this trial is testing

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

Who this might be right for
Breast Cancer, Familial MaleRadiotherapy; ComplicationsChemotherapeutic Toxicity+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 148
Not applicableStudy completedNCT03025711
What this trial is testing

Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine

Who this might be right for
Breast Neoplasms
BELEN RUIZ-ANTORAN 220
Testing effectiveness (Phase 2)UnknownNCT05749016
What this trial is testing

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Who this might be right for
Locally Advanced Breast CancerChemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableUnknownNCT01850628
What this trial is testing

NSABP Biospecimen Discovery Project

Who this might be right for
Breast Cancer
NSABP Foundation Inc 50
Testing effectiveness (Phase 2)Study completedNCT00058539
What this trial is testing

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Genentech, Inc. 42
Not applicableLooking for participantsNCT04281641
What this trial is testing

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Fudan University 94
Early research (Phase 1)Study completedNCT02060253
What this trial is testing

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT02789657
What this trial is testing

Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.

Who this might be right for
Breast Cancer
Brown University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05132582
What this trial is testing

Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 654
Testing effectiveness (Phase 2)Study completedNCT03988036
What this trial is testing

A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1)

Who this might be right for
Breast Cancer
West German Study Group 46
Load More Results